Neumora Therapeutics Overview
Neumora Therapeutics Target Price
Analysts' 12-month price predictions for NMRA.
Get informed when a big investor buys or sells
+ FollowShare Price
$1.58
Average Target Price
$4.00
153.2% upside
153.2% upside1 analysts in the last 4 months
High: $4 | Low: $4
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-18 | Mizuho Securities | $4 | 153.2% upside |  |
| 2026-01-12 | Leerink PartnersMarc Goodman | $8 | 406.3% upside | |
| 2026-01-05 | Mizuho SecuritiesGraig Suvannavejh | $6 | 279.7% upside | |
| 2025-12-01 | RBC Capital | $7 | 343% upside | |
| 2025-10-28 | Needham | $8 | 406.3% upside | |
| 2025-03-07 | Stifel Nicolaus | $2 | 26.6% upside | |
| 2025-01-02 | RBC CapitalBrian Abrahams | $4 | 153.2% upside | |
| 2024-07-22 | NeedhamAmi Fadia | $23 | 1355.7% upside | |
| 2024-07-08 | Mizuho SecuritiesGraig Suvannavejh | $20 | 1165.8% upside | |
| 2024-06-17 | RBC CapitalBrian Abrahams | $29 | 1735.4% upside | |
| 2024-03-13 | RBC CapitalBrian Abrahams | $31 | 1862% upside | |
| 2023-10-10 | Stifel NicolausPaul Matteis | $26 | 1545.6% upside | |
| 2023-10-10 | RBC CapitalBrian Abrahams | $24 | 1419% upside | |